Charles Schwab’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,060
| Closed | -$44K | – | 3550 |
|
|
2025
Q1 | $44K | Buy |
36,060
+12
| +0% | +$15 | ﹤0.01% | 3418 |
|
|
2024
Q4 | $68.1K | Sell |
36,048
-15,411
| -30% | -$29.1K | ﹤0.01% | 3424 |
|
|
2024
Q3 | $275K | Buy |
51,459
+18,287
| +55% | +$97.7K | ﹤0.01% | 3302 |
|
|
2024
Q2 | $245K | Buy |
33,172
+15,442
| +87% | +$114K | ﹤0.01% | 3411 |
|
|
2024
Q1 | $212K | Sell |
17,730
-1
| -0% | -$12 | ﹤0.01% | 3229 |
|
|
2023
Q4 | $140K | Hold |
17,731
| – | – | ﹤0.01% | 3318 |
|
|
2023
Q3 | $78.4K | Sell |
17,731
-3,125
| -15% | -$13.8K | ﹤0.01% | 3372 |
|
|
2023
Q2 | $726K | Buy |
20,856
+242
| +1% | +$8.42K | ﹤0.01% | 2884 |
|
|
2023
Q1 | $449K | Buy |
20,614
+4,151
| +25% | +$90.5K | ﹤0.01% | 2983 |
|
|
2022
Q4 | $356K | Hold |
16,463
| – | – | ﹤0.01% | 3076 |
|
|
2022
Q3 | $402K | Sell |
16,463
-86
| -0.5% | -$2.1K | ﹤0.01% | 3063 |
|
|
2022
Q2 | $338K | Buy |
16,549
+714
| +5% | +$14.6K | ﹤0.01% | 3174 |
|
|
2022
Q1 | $564K | Buy |
15,835
+4,832
| +44% | +$172K | ﹤0.01% | 3065 |
|
|
2021
Q4 | $300K | Hold |
11,003
| – | – | ﹤0.01% | 3284 |
|
|
2021
Q3 | $478K | Hold |
11,003
| – | – | ﹤0.01% | 3162 |
|
|
2021
Q2 | $548K | Buy |
11,003
+9,281
| +539% | +$462K | ﹤0.01% | 3138 |
|
|
2021
Q1 | $78K | Buy |
+1,722
| New | +$78K | ﹤0.01% | 3399 |
|